Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer

NCT00049998 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

760

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Cancer

Interventions

DRUG: topotecan

Sponsor

GlaxoSmithKline